| ESPR Stock Yearly Return 2025 Table | ||||||||||||||||||||||||||||||
ESPR average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare ESPR average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| ESPR Share Performance |
| ESPR Stock Yearly Return 2025 Chart | |||
Also see: • ESPR YTD return • ESPR average annual return 10 years | |||
| About Esperion Therapeutics Inc (New) |
| Esperion Therapeutics, Inc. is a pharmaceutical company. Co. is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Co.'s NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD). The ESPR stock yearly return is shown above.
The yearly return on the ESPR stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2025 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the ESPR annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| ESPR Current Stock Quote |
 Free ESPR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Esperion Therapeutics (ESPR) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
ETHZ Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.
Video: Don't Forget Dividends in Average Annual Return!